Skip to content

Psychedelic-assisted therapy: all studies

Page 104 of 294: studies 1,031 to 1,040 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Психоделічно-асистована терапія: ретроспективний огляд і сучасні перспективи

Lviv University Herald Series Psychological sciences October 12, 2026 Ruslan Hanushchak, Игорь Прись

У статті здійснено ретроспективний огляд розвитку психоделічної терапії та проаналізовано сучасний стан досліджень її ефективності у лікуванні психічних розладів. Простежено еволюцію використання психоделічних речовин – від традиційних духовних і лікувальних практик корінних народів через ранні клінічні дослідження середини ХХ століття до сучасного етапу, так званого «психоделічного ренесансу»....

Sacred Medicine: Use of Psychogenic Peyote within Ho-Chunk Healing

JORMA International Journal of Health and Social Sciences October 12, 2026 Michael Sersch

Current interest in the effectiveness of psychedelic-assisted recovery from trauma and other mental health conditions has been increasing. The Native American Church’s (NAC) use of the psychoactive plant peyote for over 100 years within sacred ritual has been a unique approach to religious expression and individual as well as collective healing, especially when addressing cultural trauma as...

Intercultural pathways to indigenous mental health: the integration of ayahuasca in community care in the Yaqui intercultural medicine clinic in Sonora, Mexico

Frontiers in Public Health October 9, 2026 Cecile Giovannetti, Anja Loizaga-Velder, Brian Rush et al.

Background Indigenous peoples experience substantial mental health and substance use disparities while remaining underserved by conventional healthcare systems. Despite growing evidence for psychedelic-assisted therapies, Indigenous knowledge systems and Indigenous-led models of psychedelic care remain underrepresented. This paper describes the establishment and implementation of the Yaqui...

Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation

Surgical Neurology International October 9, 2026 Andrea Garcia-Bitar, Eduardo Jesus Castañeda, José Rafael Buenrostro-Rangel et al.

Background: Neurosurgical patients carry a high and frequently undertreated burden of psychological suffering, acute and chronic pain, and neurological deficits amenable to recovery. The resurgence of psychedelic research has produced relevant evidence in adjacent fields, but its applicability to neurosurgery has not been systematized. This review synthesizes that evidence across prevention,...

Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients

Frontiers in Psychiatry October 8, 2026 Anthony L. Back, Cynthia J. Price, Bonnie A. Mcgregor et al.

Cancer patients arrive for psilocybin therapy with bodies altered by illness and treatment — bodies that they have learned to brace against, dissociate from, or scan for threat. Research on psilocybin-assisted therapy for cancer-related depression and anxiety consistently identifies the quality of the acute subjective experience — reflected in constructs such as acceptance, surrender,...

Navigating the Therapeutic Potential of Ego Dissolution

Journal of Anomalous Experience and Cognition October 6, 2026 Rebecka Malm

Ego dissolution (ED; a temporary disruption of self-boundaries and personal identity) is a central feature of many altered states of consciousness. With the resurgence of psychedelic research, these experiences have become of growing clinical relevance, as they can evoke both profound therapeutic transformation and significant psychological destabilization. This conceptual paper reviews the...

Operationalizing Excellence in Psychedelic Care Through Advancing Competencies in Nurses: State-of-the Science Review.

Issues in Mental Health Nursing October 5, 2026 JoEllen Schimmels, Madison Nobbs

As interest in psychedelic-assisted therapies grows ahead of regulatory standardization, mental health nursing stands at a critical clinical and professional inflection point. This state-of-the-science review examines psychedelic-assisted therapies through a mental health nursing lens and advocates for the formal recognition of psychedelic nursing as a specialty with defined competencies,...

Caution before canonisation: a clinical and implementation science perspective on psychedelics

Frontiers in Psychiatry October 5, 2026 Andreas Paris, Foteini Thoma, Aikaterini Velentza et al.

Recent advances in psychedelic research have renewed interest in the potential therapeutic role of psychedelic-assisted interventions in psychiatry. Early clinical trials suggest that compounds such as psilocybin and MDMA, administered within structured therapeutic frameworks, may produce rapid symptom improvements for conditions including depression, post-traumatic stress disorder, and...

Psychotherapie mit bewusstseinserweiternden Substanzen

Hypnose-ZHH October 4, 2026 Hans-Jochen Müller

Psychotherapie mit bewusstseinserweiternden Substanzen -: Zwischen klini schem Durchbruch und ethischer Verantwortung Die zunehmenden Berichte potenzieller Heilwirkungen von Psychedelika in Forschung und Medien wecken gleichermaßen Hoffnungen und Befürchtungen. Während Patient:innen Optimismus verspüren oder gar wundersame Heilungen ohne eigenes Zutun erwarten, verharren Kliniker mehrheitlich...

Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.

Molecular Psychiatry October 3, 2026 Xiubo Du, Feiyuan Peng, Xiaohui Wang

Disorders of consciousness (DoC), including coma, unresponsive wakefulness syndrome (also known as vegetative state), and minimally conscious state, represent profound disruptions in awareness and responsiveness due to severe brain injury, with limited therapeutic options available. Recent advancements in neuroimaging have improved our ability to detect residual brain activity in DoC patients,...